Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana L Antohe

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Rheumatology International|November 22, 2011
Appraising osteoporosis care gapsThomas P Olenginski, Jana L Antohe, Elaine Sunderlin, et al.
The Journal of Rheumatology|April 3, 2012
Tumor necrosis factor-α inhibitor use is not associated with lipid changes in rheumatoid arthritisAndroniki Bili, Stephanie J Morris, Jennifer A Sartorius, et al.
Arthritis Care & Research|October 6, 2011
Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapyJana L Antohe, Androniki Bili, Jennifer A Sartorius, et al.
Arthritis Care & Research|April 1, 2011
Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patientsStephanie J Morris, Mary Chester M Wasko, Jana L Antohe, et al.
Arthritis Care & Research|September 12, 2013
Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritisAndroniki Bili, Xiaoqin Tang, Shruthi Pranesh, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 29, 2011
Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patientsAndroniki Bili, Jennifer A Sartorius, H Lester Kirchner, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Rheumatology International|November 22, 2011
Appraising osteoporosis care gapsThomas P Olenginski, Jana L Antohe, Elaine Sunderlin, et al.
The Journal of Rheumatology|April 3, 2012
Tumor necrosis factor-α inhibitor use is not associated with lipid changes in rheumatoid arthritisAndroniki Bili, Stephanie J Morris, Jennifer A Sartorius, et al.
Arthritis Care & Research|October 6, 2011
Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapyJana L Antohe, Androniki Bili, Jennifer A Sartorius, et al.
Arthritis Care & Research|April 1, 2011
Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patientsStephanie J Morris, Mary Chester M Wasko, Jana L Antohe, et al.
Arthritis Care & Research|September 12, 2013
Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritisAndroniki Bili, Xiaoqin Tang, Shruthi Pranesh, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 29, 2011
Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patientsAndroniki Bili, Jennifer A Sartorius, H Lester Kirchner, et al.
Pageof 1